Latest Biotech News

Innovations in cancer treatment continue with promising therapeutic strategies. Moffitt Cancer Center identified a novel combination approach that could overcome resistance in advanced melanoma,...

Recent FDA decisions have substantially impacted drug markets and development trajectories. Novo Nordisk's Wegovy received accelerated approval for metabolic dysfunction-associated steatohepatitis...

Researchers have demonstrated several breakthroughs in nanoscale materials enhancing energy storage and biomedical applications. Advances include the development of Prussian blue analogue-derived...

Artificial intelligence is shaping breakthroughs in drug development and diagnostics. Researchers at MIT introduced COMET, a transformer-based machine learning model that accelerates design of...

Cutting-edge research continues to unravel neurodegenerative and neurodevelopmental disorders. Studies reveal that FOXP genes govern Purkinje cell diversity and cerebellar morphogenesis, advancing...

Recent studies spotlight innovations in agriculture and environmental sciences driven by biotechnology. The Danforth Center allocated proof-of-concept funding to accelerate transformative plant...

Innovation in clinical and diagnostic realms advances care for challenging diseases. A microfluidic platform mimicking blood microenvironments enables monitoring of tick-borne parasite spread,...

Recent analyses depict robust financial dynamics and strategic market shifts within healthcare. A study highlights contract research organizations’ (CRO) role in enhancing drug development...

Tel Aviv University researchers have advanced regenerative biotechnology by cultivating human spinal cord stem cells in the lab, progressing toward the first-ever transplant in a paralyzed...

The FDA granted accelerated approval to Novo Nordisk’s Wegovy, a GLP-1 receptor agonist, for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), marking the drug...

Skyhawk Therapeutics entered a neurology-focused collaboration with Merck KGaA, potentially worth over $2 billion, targeting RNA splicing modulation for difficult-to-treat neurological diseases....

Kriya Therapeutics secured $313 million in a new funding round, making it one of the largest private biotech fundraises this year. The company develops gene therapies across neurology, metabolic...

Stealth BioTherapeutics has resubmitted its drug application for an ultra-rare Barth syndrome therapy following an FDA rejection earlier this year. The company has struggled to align with the...

New data from clinical trials highlight breakthroughs in immunotherapy for hard-to-treat cancers. The phase 2 TD-NICE trial shows favorable four-year outcomes combining tislelizumab with...

MIT researchers developed Composite Material Transformer (COMET), an AI-powered machine learning model, optimizing lipid nanoparticle (LNP) formulations for RNA delivery. COMET predicts efficient...

Recent research at MIT and Cambridge has illuminated how large language models (LLMs) trained on protein sequence data can predict structure and function, deepening our understanding of protein...

Australian CSIRO scientists, collaborating internationally, have proposed a novel public health surveillance system utilizing aircraft wastewater to monitor antimicrobial resistance (AMR)...

Harvard’s Wyss Institute pioneered a stem cell differentiation technique that directly induces meiosis from human iPSCs, bypassing intermediate stages, fostering the generation of gametes in...

The U.S. Department of Health and Human Services' decision to reduce funding for mRNA vaccine research has drawn criticism from the scientific community. Experts warn that this cut could weaken...

Swedish biotech firm Anocca secured $46 million to support clinical development of VIDAR-1, a nonviral genome-edited T-cell receptor (TCR) T-cell therapy targeting mutant KRAS in pancreatic ductal...